Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS

Second-generation antipsychotics in major depressive disorder: update and clinical perspective

(2010) Jun Chen et al.   CURRENT OPINION IN PSYCHIATRY

RETRACTED: Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine

(2010) Georg Nikisch et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Development and validation of an LC–MS/MS method for the determination of quetiapine and four related metabolites in human plasma

(2009) Patricia C. Davis et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

UPLC–MS–MS Analysis of Quetiapine and Its Two Active Metabolites, 7-Hydroxyquetiapine and 7-Hydroxy-N-dealkylquetiapine, in Rat Plasma and Cerebrospinal Fluid

(2008) Ji-Ying Tu et al.   CHROMATOGRAPHIA

Steady-State Pharmacokinetic, Safety, and Tolerability Profiles of Quetiapine, Norquetiapine, and Other Quetiapine Metabolites in Pediatric and Adult Patients with Psychotic Disorders

(2008) Helen R. Winter et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Preliminary evaluation of monolithic column high-performance liquid chromatography with tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection for the determination of quetiapine in human body fluids

(2008) S BELLOMARINO et al.   TALANTA

Detection and identification of atypical quetiapine metabolite in urine

(2008) Vasil Atanasov et al.   Open Medicine